FDA and the Centers for Medicare and Medicaid Services have accepted the FoundationOne comprehensive genomic profiling assay for parallel review. FDA also accepted Foundation Medicine’s request for review as part of its Expedited Access Pathway for breakthrough devices. If approved, the assay would be the first to incorporate multiple companion diagnostics to support precision medicine […]
FDA granted Breakthrough Therapy designation to LEE011 (ribociclib), in combination with letrozole, for the treatment of hormone receptor positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer. LEE011 is a selective cyclin dependent kinase (CDK4/6) inhibitor.
THE COMMUNITY ONCOLOGY ALLIANCE launched the Advanced Practice Provider Network, for oncology nurse practitioners, physician assistants and others. The network consists of a private, peer-to-peer-only information sharing website and listserv; monthly conference calls to review important practice issues and discuss solutions; and opportunities for in-person meetings. Participation in the network is open and free of […]
VANDERBILT-INGRAM CANCER CENTER received a $3 million, three-year grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, in support of VICC’s drug discovery program. “We are profoundly grateful to the Foundation for their support of this vitally important cancer drug discovery research initiative,” said Scott Hiebert, Hortense B. Ingram Professor of Cancer […]
UT SOUTHWESTERN MEDICAL CENTER's Harold C. Simmons Comprehensive Cancer Center received $11 million in SPORE funding from NCI to support its Kidney Cancer Program.
NATASCIA MARINO was named a Breast Cancer Research Foundation Investigator at the Indiana University School of Medicine. Marino, also an assistant research professor of medicine, is an investigator with the Susan G. Komen Tissue Bank at the IU Simon Cancer Center. Her research focuses on the normal breast and how it relates to the development […]
CHRISTOPHER MANLEY and KRISTEN SCULLY MANLEY joined Fox Chase Cancer Center. Christopher Manley will serve as the director of interventional pulmonology in the Department of Medicine, and Kristen Scully Manley will serve as a hospitalist in the department of medicine. “Dr. Manley’s expertise in pulmonary medicine makes him the perfect candidate for our new director […]
PIERRE MASSION will direct the Vanderbilt-Ingram Cancer Center’s Cancer Early Detection and Prevention Initiative. Massion is the Cornelius Vanderbilt Professor of Medicine, an Ingram Professor of Cancer Research and co-leader of the VICC Cancer Health Outcomes and Control Research Program. “The prevention of cancer and the development of more effective strategies to detect cancer precursors […]
THE UNIVERSITY OF PITTSBURGH CANCER INSTITUTE, partnered with UPMC CancerCancer, received a contract from NCI to perform preclinical research for the development of new cancer drugs. This commitment could bring up to $10 million in research projects to UPCI over the next five years. Julie Eiseman, professor of pharmacology and chemical biology, and Jan Beumer, […]
DANA-FARBER CANCER INSTITUTE received $100 million for a portion of its interest in royalties related to its Programmed Death Ligand-1 intellectual property. CPPIB Credit Europe S.à r.l., a wholly owned subsidiary of Canada Pension Plan Investment Board, paid $100 million upfront, and has committed to pay up to $68 million in additional payments, subject to […]
